Dr. Simeon Jaggernauth, DO

Bio

Dr.Jaggernauth aka "Dr. JAG" is a dual Board Certified Medical Oncologist by the American College of Physicians. He completed his doctorate at Oklahoma State University, his residency at the University of Oklahoma, and fellowship in Medical Oncology at the University of Louisville at the renowned James Graham Brown Cancer Center. Dr. Jaggernauth is certified by the National Institutes of Health (NIH) for conduction of clinical trials in humans. He is the principal investigator and sub-investigator for multiple clinical trials in treatment of metastatic breast, colon and lung cancers. His area of emphasis is on advanced cancers of the digestive track and Gastrointestinal System. He practices at the Cancer Treatment Centers of America where he treats cancer of the Esophagus, Stomach, Intestines, Colon, Liver,Pancreas and Anus in addition to various common cancers. Dr.Jaggernauth also serves as the Program Director of Medical Oncology for Oklahoma State University College of Medicine fellowship. He is responsible for training young doctors to become cancer fighters as Medical Oncologists. He has presented at numerous medical conferences and has been published in the Journal of Clinical Oncology and Breast Cancer Wellness Magazine. He is a member of the American Society of Clinical Oncology (ASCO), and has been featured on ABC and FOX News regarding cancer in various celebrities. As an active member of the community, Dr. Jaggernauth has participated in and helped sponsor the local Susan G. Komen Race for the Cure. To learn more about him visit: www.DRJAG.com

Specialties:

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Oncology:

    WEDNESDAY, March 4, 2015 (HealthDay News) -- Breast cancer chemotherapy can trigger an unfortunate side effect for some patients -- early menopause.

    But a new study suggests that adding the drug goserelin to chemotherapy cuts the odds of that happening in women with certain early-stage ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    WEDNESDAY, March 4, 2015 (HealthDay News) -- U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small cell lung cancer (NSCLC), the agency said Wednesday in a news release.

    Lung cancer is the leading cause of cancer death in the Unit...Full Article

  • Sharecare News
    Sharecare News posted a story about Pediatrics:

    MONDAY, March 2, 2015 (HealthDay News) -- It's easy for teens to buy electronic cigarettes online, a small study finds.

    Researchers supervised 11 teens in North Carolina, aged 14 to 17, as they tried to buy e-cigarettes from 98 online sellers. The teens ordered ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, Feb. 26, 2015 (HealthDay News) -- For many people, an increase in genetic mutations that could trigger leukemia seems to be an inevitable part of aging, a new study finds.

    The British researchers looked specifically at mutations in blood stem cells.

    "Over time, the proba...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    TUESDAY, Feb. 24, 2015 (HealthDay News) -- U.S. recommendations against the PSA test for prostate cancer might have prompted a small but measurable increase in the number of higher-risk cases diagnosed recently, according to a new study.

    The U.S. Preventive Services Task Force (USPSTF) in...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    TUESDAY, Feb. 24, 2015 (HealthDay News) -- The area of the colon where a cancer develops may play a role in a patient's survival, a new study suggests.

    Researchers report that people with colon cancer that started in the left colon may be more likely to survive than those whose disease or...Full Article

  • Sharecare News
    Sharecare News posted a story about Addiction Medicine:

    TUESDAY, Feb. 24, 2015 (HealthDay News) -- Two-thirds of smokers will die early from their habit if they don't quit, a new study suggests.

    The findings indicate that it's never too late to quit smoking, one expert said.

    Researchers analyzed data from more than 200,000 people takin...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    TUESDAY, Feb. 24, 2015 (HealthDay News) -- Farydak (panobinostat) has been approved by the U.S. Food and Drug Administration to treat multiple myeloma, a cancer of the blood.

    Affecting mostly older adults, the disease causes blood plasma cells to multiply rapidly, overtaking other healthy...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    MONDAY, Feb. 23, 2015 (HealthDay News) -- Choosing active surveillance over treatment for prostate cancer may decrease the odds of survival in men with intermediate-risk cancer, a new study says.

    The risk of death over 15 years for men with intermediate-risk prostate cancers who chose clo...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    MONDAY, Feb. 23, 2015 (HealthDay News) -- Men who've had testicular cancer may be at increased risk for prostate cancer, although that risk is low, a new study finds.

    "Men with a history of testicular cancer should talk with their doctor about assessing their risk for prostate cancer, giv...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    THURSDAY, Feb. 19, 2015 (HealthDay News) -- Educating women about the possibility of "overdiagnosis" from mammography screening may make some of them less likely to get the test, a new study says.

    One expert said the findings are important.

    "The take-home message needs to be that ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, Feb. 19, 2015 (HealthDay News) -- New research suggests that a wait-and-watch approach for prostate cancer isn't being used often enough, and that more men are being treated than may be necessary.

    Additionally, the researchers expressed concern about the numbers of men being tr...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, Feb. 19, 2015 (HealthDay News) -- Survival rates are improving for many people with cancers of the breast, prostate, lung, liver and colon or rectum, especially for those diagnosed at younger ages, a new study reports.

    Cancer is still a leading cause of death in the United State...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    THURSDAY, Feb. 19, 2015 (HealthDay News) -- Skin damage caused by ultraviolet (UV) radiation continues long after you get out of the sun, even in the dark, a new study says.

    Researchers explain that UV light from the sun or tanning beds can damage DNA in melanocytes. Melanocytes are cells...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, Feb. 19, 2015 (HealthDay News) -- A small power tool that is sometimes used to remove fibroids in the uterus can end up spreading bits of hidden cancerous tumors throughout the abdomen, but a new study suggests the likelihood is low.

    Researchers called the findings, reported onl...Full Article